Abstract:Taenia solium is a tapeworm that causes taeniosis in humans and cysticercosis in humans and pigs. Within Eastern and Southern Africa (ESA), information on the presence of human taeniosis and cysticercosis seems scarce. This systematic review aimed to describe the current information available and gaps in the epidemiology of human T . solium infections in ESA. Scientific literature published between 1 st January 2000 and 20 th June 2022 in international databases [MEDLINE (Ovid), Embase (Ovid), Global Health (Ovid), Scopus (Elsevier), African Index Medicus (via WHO Global Index Medicus), and Open Grey] was systematically reviewed for ESA. The study area included 27 countries that make up the ESA region. Information on either taeniosis, cysticercosis or NCC was available for 16 of 27 countries within the region and a total of 113 reports were retained for the review. Most case reports for cysticercosis and NCC were from South Africa, while Tanzania had the most aggregated cysticercosis reports. Eleven countries reported on NCC with seven countries reporting data on NCC and epilepsy. Unconfirmed human T . solium taeniosis cases were reported in nine countries while two countries (Madagascar and Zambia) reported confirmed T . solium cases. The cysticercosis seroprevalence ranged between 0.7–40.8% on antigen (Ag) ELISA and between 13.1–45.3% on antibody (Ab) ELISA. Based on immunoblot tests the Ab seroprevalence was between 1.7–39.3%, while the proportion of NCC-suggestive lesions on brain CT scans was between 1.0–76% depending on the study population. The human taeniosis prevalence based on microscopy ranged between 0.1–14.7%. Based on Copro Ag-ELISA studies conducted in Kenya, Rwanda, Tanzania, and Zambia, the highest prevalence of 19.7% was reported in Kenya. Despite the public health and economic impact of T . solium in ESA, there are still large gaps in knowledge about the occurrence of the parasite, and the resulting One Health disease complex, and monitoring of T . solium taeniosis and cysticercosis is mostly not in place. Taenia solium is a tapeworm that causes three diseases, taeniosis in humans and cysticercosis in humans and pigs. Neurocysticercosis, which occurs when the central nervous system is involved has been associated with up to 57% of epilepsy cases in sub–Saharan Africa. Diagnosing neurocysticercosis among people with epilepsy is vital to prevent further morbidity and mortality from the disease as well as to reduce the negative socio-cultural beliefs associated with epilepsy. Within Eastern and Southern Africa, there are many countries in which information on the presence of human taeniosis, cysticercosis and neurocysticercosis seems scarce. This systematic review aimed to describe the current information available and gaps in the epidemiology of human T . solium infections in Eastern and Southern Africa. We found that Information on either taeniosis, cysticercosis or NCC was available only for 16 of 27 countries within the region. We also found that most of the studies on T . solium taeniosis, cysticercosis and neurocysticercosis within the region have been done in Kenya, Madagascar, Mozambique, Rwanda, South Africa, Tanzania and Zambia. Understanding the epidemiology of T . solium infections is essential for monitoring, prevention and control of the disease complex in a One Health approach.

Pathogenesis of Taenia solium taeniasis and cysticercosis

Taenia solium Cysticercosis and Its Impact in Neurological Disease

Host immune responses during Taenia solium Neurocysticercosis infection and treatment

Diagnosis, treatment and control of Taenia solium cysticercosis

Human Neurocysticercosis: An Overview

Characterization of antigenic proteins of the Taenia solium postoncospheral form

Control of the taeniosis/cysticercosis complex: future developments

Neurocysticercosis and Epilepsy: Imaging and Clinical Characteristics.

Neurocysticercosis: A Review

Transcriptomic analysis of subarachnoid cysts of Taenia solium reveals mechanisms for uncontrolled proliferation and adaptations to the microenvironment

The epidemiology of human Taenia solium infections: A systematic review of the distribution in Eastern and Southern Africa

Understanding the pathogenic mechanisms and therapeutic effects in neurocysticercosis

Neurocysticercosis: Current Perspectives on Diagnosis and Management

Taenia solium Taeniasis and Cysticercosis in Southeast Asia

Mass Spectrometry Identifies Taenia solium Proteins in Sera of Patients With and Without Parenchymal Neurocysticercosis

The Parasitological, Immunological, and Molecular Diagnosis of Human Taeniasis with Special Emphasis on Taenia solium Taeniasis

Proteomic analysis of Taenia solium cysticercus and adult stages

NEW CONCEPTS IN THE DIAGNOSIS AND MANAGEMENT OF NEUROCYSTICERCOSIS (TAENIA SOLIUM)

Identification and culture of proliferative cells in abnormal Taenia solium larvae: Role in the development of racemose neurocysticercosis

Ultraphatological Observation on the Small Brain Abscess Caused by Cysticerci of Taenia a Solium: a Double · Necrosis (apoptosis) Theory about the Formation and Development of the Abscesses

A CASE OF NEUROCYSTICERCOSIS PRESENTED WITH SEIZURES: A CASE REPORT